Certara Announces Financial Results Meeting
Certara, Inc. (NASDAQ: CERT), a global leader in biosimulation, is gearing up to share its third quarter financial performance for 2025. The announcement comes as part of the company's commitment to transparency and investor engagement.
Conference Call Details
Scheduled for Thursday, November 6, 2025, Certara plans to release its financial results following the market closure. This will allow investors ample opportunity to analyze the data and prepare any questions they might have. At 5:00 PM ET on the same day, management will host a conference call aimed at discussing these results and providing insights into the company's future strategies.
How to Participate in the Conference Call
For those interested in joining the discussion, it's essential to register ahead of time. Certara recommends signing up at least a day prior to the call to ensure your participation. Those who register will gain the opportunity to engage directly with company leadership and hear about the insights they have to share.
Availability of Live and Archived Webcast
In this digital age, accessibility is vital. Certara will provide both a live and an archived webcast of the financial results call. Investors can find this in the "Investors" section of the company’s website. This way, even if someone cannot attend live, they have the chance to catch up on what was discussed at their convenience.
Understanding Certara's Role in Biosimulation
Certara stands out for its innovative approach to drug discovery and development through biosimulation technology. This method not only helps accelerate the medicine development process but also improves the accuracy of predictions made during the research phase. The company boasts a customer base of over 2,400 organizations, spanning biopharmaceutical companies, universities, and regulatory bodies in over 70 countries worldwide.
Recent Developments at Certara
Recently, Certara has been focusing on enhancing its biosimulation software and services, which have been crucial during a time of rapid advancements in the pharmaceutical industry. With the ongoing demand for efficient and effective drug development approaches, Certara's work has never been more relevant. The integration of advanced technologies continues to position them as key players in transforming traditional methods of drug discovery.
Investor Relations Contact
For additional inquiries or more information, investors can reach out to David Deuchler at Gilmartin Group via email. It's essential for stakeholders to stay informed about the company’s activities and insights.
Media Inquiries
Alyssa Horowitz handles the media relations at Certara and can provide further information as needed. Staying connected through communication opens up opportunities for broader understanding of Certara's mission and progress in the industry.
Frequently Asked Questions
When will Certara release its Q3 financial results?
Certara will release its financial results on November 6, 2025, after market close.
How can I participate in Certara's conference call?
Interested participants should register online at least one day in advance to join the call scheduled for 5:00 PM ET on November 6, 2025.
Will the conference call be available after it airs?
Yes, Certara will provide an archived webcast on their website, allowing anyone to listen post-event.
What services does Certara provide?
Certara specializes in biosimulation software and technologies that aid in drug discovery and development, serving clients worldwide.
Who can I contact for investor relations inquiries at Certara?
David Deuchler from Gilmartin Group handles investor relations and can be contacted for related inquiries.
